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Chromosome breakage elicits transient silencing of ribosomal RNA synthesis, 
but the mechanisms involved remained elusive. Here we discover an in-trans 
signaling mechanism that triggers pan-nuclear silencing of rRNA transcription 
in response to DNA damage. This is associated with transient recruitment of the 
Nijmegen breakage syndrome protein 1 (NBS1), a central regulator of DNA 
damage responses, into the nucleoli. We further identified TCOF1-Treacle, a 
nucleolar factor implicated in ribosome biogenesis and mutated in Treacher-
Collins syndrome, as an interaction partner of NBS1, and demonstrate that 
NBS1 translocation and accumulation in the nucleoli is Treacle-dependent. 
Finally, we provide evidence that Treacle-mediated NBS1 recruitment into the 
nucleoli regulates rRNA silencing in-trans in the presence of distant chromosome 
breaks. 
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The inability to properly respond to DNA damage leads to various disorders and 
enhanced rates of tumor development in mammals. To avoid genome instability, cells 
respond to DNA damage by activating a complex network of signaling pathways, 
collectively termed the DNA damage response (DDR), which is designed for 
detecting, signaling and repairing of aberrant DNA structures 1.  
A central player in the DDR is the ATM protein, a large Serine-Threonine kinase that 
is activated by DNA double-strand breaks (DSBs) and is mutated in the genome 
instability syndrome Ataxia telangiectasia (AT) 2. Several proteins are implicated in 
efficient recruitment of ATM to sites of DSBs and its subsequent activation: NBS1 
for example, which is a subunit of the conserved MRE11-RAD50-NBS1 (MRN) 
complex, directly interacts with ATM, and the MRN complex is involved in the 
efficient activation of ATM in response to DSBs 3. NBS1 is mutated in Nijmegen 
breakage syndrome (NBS), a rare autosomal recessive congenital disorder that is 
associated with short stature, cranio-facial abnormalities including microcephaly, 
mild mental retardation, immunodeficiency and a strong predisposition to lymphoid 
malignancy 4. 
Other proteins such as the phosphorylated form of the histone variant H2AX (termed 
γH2AX) and the adaptor MDC1 help to establish a specialized chromatin 
environment in the regions flanking DSBs, a process believed to enhance and 
maintain the ATM-dependent DNA damage signaling pathways 5. Recruitment and 
accumulation of the MRN complex at sites of DSBs requires the direct interaction 
between a unique divalent Forkhead-associated (FHA)-tandem BRCA1 C-terminal 
(BRCT) phosphopeptide-binding architecture located at the N-terminus of NBS1, 
with a constitutively phosphorylated acidic repeat region in MDC1 (SDT repeat 
region; 6-11).  
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Induction of DSBs triggers transient inhibition of cell cycle progression (so-called cell 
cycle checkpoints), especially during S-phase and at the G2-M border. Whether the 
transcriptional machinery is similarly affected by the presence of DSBs remains a 
long-standing question. Recent evidence suggests that ATM-dependent signaling 
cascades can also suppress transcription. For example, an ATM-dependent 
transcriptional silencing mechanism prevented RNA polymerase II (Pol II) 
elongation-dependent chromatin decondensation at regions distal to DSBs 12. In 
addition, ATM-dependent signaling was shown to inhibit local RNA polymerase I 
(Pol I) transcription in the nucleoli in response to chromosome breaks 13. In both cases, 
transcriptional silencing seemed to be limited to chromatin regions that are closely 
located to the sites of breaks and a pan-nuclear transcriptional silencing mechanism in 
response to DNA damage has so far not been described.  
Here we describe an ATM-dependent in-trans signaling mechanism that triggers pan-
nuclear silencing of Pol I transcription in response to DNA breaks. Furthermore we 
present evidence that in-trans inhibition of rRNA synthesis is regulated by rapid and 
transient DNA damage-induced nucleolar translocation and accumulation of NBS1, a 
process that is regulated by ATM and is dependent on direct interaction between 
NBS1 and the nucleolar factor TCOF1-Treacle. In summary, our findings reveal an 
unexpected trans-compartmental communication between sites of DNA damage and 
Pol I mediated transcription in the nucleoli.  
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RESULTS 
In-trans inhibition of Pol I transcription in response to DNA damage is 
associated with NBS1 recruitment into the nucleoli. 
It was previously shown that laser micro-irradiation of an individual nucleolus leads 
to transient silencing of rRNA synthesis within this nucleolus, while transcription in 
the other nucleoli of the same cell was unaffected 13.  
In order to test whether induction of DSBs outside of the nculeolar compartment had 
the capacity to trigger rRNA silencing in trans we established an imaging-based assay 
that combined laser micro-irradiation with 5-EU RNA labeling followed by Click-iT 
chemistry. Surprisingly, we found that irradiation of any sub-nuclear region had a 
pronounced effect on rRNA transcription in all of the nucleoli of the irradiated cells 
irrespective of whether or not they were directly hit by the laser beam (Fig. 1a and 
Supplementary Fig. 1a). This suggests the existence of an as yet unidentified in-
trans signaling mechanism that transduces the signal generated by the presence of 
chromosome breaks into the nucleoli. Further support of such an in-trans signaling 
mechanism came from the observation that low doses of IR gave a very similar 
degree of rRNA inhibition as compared to high-dose treatment (Supplementary Fig. 
2a).  
Since Pol I silencing in-cis after exposure of cells to IR was shown to be dependent 
on ATM signaling and on the presence of the two DDR mediator-adaptor proteins 
MDC1 and NBS1 13, we asked if these factors were also involved in this trans-
compartmental signaling mechanism. While in our hands MDC1 depletion had only a 
minor effect we found that rRNA repression was dependent on ATM signaling and on 
NBS1, consistent with previous findings 13 (Supplementary Fig. 3).  
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In support of a functional implication of NBS1 in rRNA silencing in response to DNA 
damage, we observed a focal pattern of GFP-tagged NBS1 in the nucleus that 
increased after laser micro-irradiation (Fig. 1b). These distinct NBS1-GFP foci co-
localized with nucleolar Fibrillarin, suggesting bona fide nucleolar relocalization 
(Supplementary Fig. 1b).  Interestingly, GFP-tagged MRE11 did not show this inter-
compartmental dynamics in response to DNA damage (Supplementary Fig. 1d). We 
observed the same focal pattern of endogenous NBS1 in the nucleoli 10 min. after 5 
Gy of IR, although the endogenous nucleolar NBS1 foci were smaller than the NBS1-
GFP-decorated structures. Again, no signal associated with endogenous MRE11could 
be detected, thus suggesting an MRE11-independent function of NBS1 (Fig. 1c). 
Consistently, we also found that rRNA silencing in response to DNA damage was 
NBS1-dependent but MRE11-independent (Supplementary Fig. 2b). 
We then combined laser micro-irradiation with real-time imaging (reviewed in 14) and 
observed a rapid accumulation of NBS1 around the DSB-containing subnuclear tracks 
and with a small temporal delay, the focal NBS1-GFP pattern appearing in the 
nucleoli (Supplementary Fig. 1c). While NBS1-GFP stably associated at sites of 
laser damage for the entire duration of the experiment (70 min; see Fig. 1d) the 
nucleolar NBS1-GFP signal reached a maximum at around 15 min post irradiation 
and gradually decreased, reaching background levels at around 40 min. The kinetics 
of NBS1 recruitment into the nucleoli perfectly matched the kinetics of rRNA 
silencing in response to DNA damage (compare Fig. 1d to e), thus suggesting that 
these two events are functionally linked. In summary, these data reveal that DNA 
damage-induced in-trans silencing of Pol I transcription is associated with 
relocalization of a fraction of NBS1 into the nucleoli. 
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NBS1 is enriched at sites of rRNA transcription in response to DNA damage. 
Immunofluorescence analysis in laser micro-irradiated cells showed that NBS1-GFP 
nucleolar foci co-localized with Pol I in the dense fibrillar components of the nucleoli 
where active transcription of rDNA takes place (Fig. 2a). To directly show NBS1 
enrichment within transcribed regions of the nucleoli we used chromatin 
immunoprecipitation (ChIP) followed by quantitative real time PCR (qRT-PCR) in 
NBS1-GFP expressing cell lines. The primer pairs for the qRT-PCR included a 
promoter region 5’ of the transcription start site (H0), a segment inside the coding 
region of the primary transcript (H1) and a region within the intergenic spacer (H18) 
of rDNA. A primer pair from the GAPDH gene served as a negative control (see Fig. 
2b). ChIP data showed that similar to Pol I, NBS1-GFP is present at the rDNA 
promoter (H0) and more abundant within the coding region (H1) (Fig. 2c,d). 
Moreover, Pol I localization at the transcriptional start site and within the coding 
region was not dramatically affected upon IR treatment (Fig. 2c), while NBS1-GFP 
association with transcribed regions of the rDNA increased after IR, thus suggesting a 
DNA damage-induced recruitment of NBS1 into actively transcribed regions within 
the nucleoli (Fig. 2d). 
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The NBS1 FHA domain mediates nucleolar accumulation of NBS1. 
Consistent with Pol I silencing in response to DNA damage being ATM-dependent 
(Supplementary Fig. 3a; 13), we observed a significant reduction of the percentage of 
laser micro-irradiated cells with nucleolar NBS1 upon depletion of ATM by RNA 
interference (Fig. 3a). NBS1 itself is an ATM target but a mutant derivative of NBS1 
lacking the three ATM phosphorylation sites (3A mutant) was still efficiently forming 
nucleolar foci upon laser micro-irradiation, indicating that NBS1 phosphorylation by 
ATM is not required for its nucleolar translocation (Fig. 3b).  
NBS1 recruitment into γH2AX-marked chromatin regions at sites of DSBs is 
mediated by MDC1. However, MDC1 depletion by siRNA did not provoke a 
reduction in nucleolar NBS1-GFP accumulation, even though NBS1 recruitment to 
sites of DSBs was significantly reduced under these conditions (Fig. 3c). Interestingly 
though, a mutation in the N-terminal FHA-BRCT region of NBS1 that abrogates its 
ability to interact with phosphorylated proteins (R28A10), led to a complete loss of 
nucleolar residence and DNA damage-induced nucleolar enrichment of NBS1-GFP 
(Fig. 3d). These data strongly suggest that an as yet unidentified phosphorylation-
dependent interaction partner of NBS1 that is distinct from MDC1 mediates its 
nucleolar recruitment in response to DNA damage. 
 
Treacle is a NBS1 FHA-BRCT-interacting protein. 
In order to identify NBS1 FHA-BRCT-interacting proteins that may mediate trans-
compartmental enrichment of NBS1 in the nucleoli we performed an unbiased 
proteomic screen (see Methods for details). The first N-terminal 382 amino acids of 
human NBS1 were used as bait and were C-terminally modified with two affinity tags 
(Strep, HA; see Fig. 4a). One construct was wild type, the other carried the R28A 
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point mutation in the FHA domain, which completely abrogated nucleolar residence 
of NBS1 (see above). Protein complexes were isolated from untreated cells and from 
cells treated with 10 Gy of IR by double affinity purification. Retained proteins were 
then identified by mass spectrometry.  
As expected, unique NBS1 bait peptides were identified in all four purifications (Fig. 
4b). MDC1 was only co-purified with wild type NBS1 FHA-BRCT and the 
interaction was not altered upon IR in agreement with published results. 6,7,15,16. 
Interestingly, several nucleolar proteins co-purified with the NBS1 FHA-BRCT 
region. Most pronounced according to the number of unique peptides was TCOF1 
(Fig. 4b). The TCOF1 gene encodes a low complexity nucleolar phosphoprotein often 
referred to as Treacle. TCOF1 is mutated in Treacher-Collins syndrome (TCS), one of 
the most severe autosomal dominant congenital disorders of craniofacial development. 
Functionally, TCOF1-Treacle has been implicated in the spatiotemporal control of 
ribosome biosynthesis, most notably in rRNA transcription and pre-ribosomal RNA 
processing (reviewed in 17).  
We first confirmed the interaction between NBS1 and Treacle biochemically by GST 
pull down experiments with bacterially purified NBS1 N-terminal fragments. Wild 
type NBS1-GST (amino acids 1-382) but not an NBS1 FHA-BRCT double mutant 
(DM: R28A, K160M) pulled down detectable amounts of Treacle from the extract, 
indicating that interaction of the NBS1 FHA-BRCT region with Treacle requires 
intact FHA and BRCT phosphopeptide-binding functions (Fig. 4c). 
Co-immunoprecipitation experiments with over expressed tagged proteins showed 
that full-length Strep-tagged Treacle could retrieve endogenous NBS1 from cell 
extracts (Fig. 4d). Moreover, a wild type Flag-HA-tagged N-terminal NBS1 fragment 
efficiently co-immunoprecipitated with endogenous Treacle, while the FHA mutated 
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fragment (R28A) and the double-mutant fragment (DM: R28A, K160M) did not. The 
BRCT mutated fragment (K160M) showed residual binding activity, albeit 
significantly weaker than the wild type (Fig. 4e). This indicates that the NBS1 FHA 
domain is the predominant interaction partner of Treacle in vitro and that the NBS1 
BRCT domains also partially contribute to the interaction.  
Endogenous Treacle also co-immunoprecipitated with endogenous NBS1 (Fig. 4f) 
and, as already shown in the mass spectrometry analysis, Treacle association with 
NBS1 was not dependent on DNA damage (Fig. 4e,f).  
 
NBS1 binds to conserved phosphorylated SDT-like motifs in Treacle. 
Treacle consists of three structurally distinct regions: an N-terminal region, a central 
region consisting of 10 consecutive acidic and Ser-rich sequence stretches and a C-
terminal region containing nuclear and nucleolar localization signals 18 (Fig. 5a). 
Treacle interacts with CK2 19 and its primary sequence contains numerous potential 
CK2 phosphorylation sites. We found that bacterially purified Treacle fragments are 
heavily phosphorylated by CK2 in vitro, especially within the repeat region 
(Supplementary Fig. 4). In order to map the NBS1 interaction site we systematically 
deleted the individual domains of Treacle in order to assess their impact on the 
interaction with NBS1	  (Fig. 5b).	  These experiments suggested that the major NBS1 
interaction site is located within the N-terminal 225 amino acids of Treacle with a 
potential minor contribution of the C-terminal region.  
A purified GST fragment of this region was efficiently phosphorylated by CK2 in 
vitro (Supplementary Fig. 4; T-2) and this fragment pulled down the MRN complex 
from Hela nuclear extracts only when previously phosphorylated by CK2 (Fig. 5c). 
Notably, this N-terminal region of Treacle features three motifs that are highly 
	   11	  
reminiscent of the previously described MDC1 SDT motifs 6-9 and form CK2 
consensus sites (Fig. 5d). The first motif consists of a Ser residue followed by a Glu 
and Thr, flanked by three consecutive Glu residues (SETE amino acids 171-174). 
Further downstream two additional sequence stretches show similarity to the MDC1 
SDT motifs: a Ser residue followed by two acidic amino acids and by a Thr residue 
(SEDT, amino acid 200-203 and SDET, amino acid 207-210, respectively).  
To fine-map the NBS1 interaction site in Treacle we assessed the binding affinity of 
phosphopeptides derived from this region by isothermal titration calorimetry (ITC) 
(Fig. 5e). The SDET motif around Thr 210 showed the highest binding affinity with a 
Kd around 1 µM.  
 
Phosphorylated Thr 210 in Treacle is the major interaction site for NBS1 
We next mutated Thr 210 to Ala in the context of full-length HA-tagged Treacle and 
analyzed its binding to Flag-tagged N-terminal NBS1 in 293T cell extracts by Flag 
immunoprecipitation (Fig. 6a). The T210A mutant was completely deficient for 
NBS1 interaction and we did not observe a further decrease by additional Ser-Thr 
substitutions. Mutation of the SETE motif led to a significant reduction in NBS1 
binding but did not abrogate it (Fig. 6b), thus suggesting that sequence around Thr 
210 is the predominant NBS1-interaction site in Treacle, with a minor contribution of 
the region around Thr 173. 
Next we sought to confirm that Thr 210 is phosphorylated in vivo. Proteins extracted 
from GFP-Treacle-expressing 293T cells were sequentially digested with Trypsin and 
Asp-N, followed by an enrichment of CK2 phosphopeptides through an affinity resin 
(Fig. 6c; see Methods for detail). This approach led to the unambiguous identification 
of a short peptide sequence harboring Thr 210 of Treacle (Fig. 6d), and the mass of 
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this peptide reveals Thr 210 as being phosphorylated (Fig. 6e). Collectively, these 
data strongly indicate that Thr 210 is indeed phosphorylated by CK2 in vivo, and that 
this modification constitutes the major interaction site for NBS1.  
 
Treacle mediates NBS1 nucleolar translocation in response to DNA damage and 
a small fraction of it is transiently recruited to sites of DNA damage. 
Treacle has originally been described as a nucleolar protein that interacts with 
upstream binding factor (UBF), an RNA Pol I transcription factor. Indeed, we 
confirmed nucleolar localization of Treacle and co-localization with UBF by 
immunofluorescence (Supplementary Fig. 5a). Treacle staining is most pronounced 
in the dense fibrillar components of the nucleolus where the rDNA transcription takes 
place, and Treacle and Fibrillarin foci co-localize (Fig. 7a 19).  
Interestingly, upon induction of DSBs by laser micro-irradiation, NBS1-GFP 
nucleolar foci co-localized with Treacle, indicating that they occupied the same 
fibrillar structures after DNA damage (Fig. 7b). ChIP experiments in stable GFP-
Treacle-expressing cell lines confirmed that similar to Pol I, Treacle mainly occupies 
the promoter and coding regions of the rRNA gene arrays (Supplementary Fig. 5b). 
Significantly, depletion of Treacle by siRNA led to a complete loss of NBS1-GFP 
nucleolar localization and accumulation in response to DNA damage, thus revealing 
that Treacle acts as a mediator for DNA damage-induced recruitment of NBS1 in the 
nucleoli (Fig. 7c).  
Based on sequence similarity of Treacle with Nopp140, a trafficking nucleolar 
phosphoprotein that shuttles between the nucleolus, the cytoplasm and Cajal bodies 20, 
it was speculated that Treacle might also be trafficking to other cellular compartments 
19. Indeed, fluorescence recovery after photobleaching (FRAP) experiments in cells 
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expressing a GFP-tagged version of the full-length Treacle cDNA revealed that GFP-
Treacle is a mobile protein that shuttles between the nucleoplasm and the nucleoli 
(Supplementary Fig. 5c). We next sought to determine if nucleoplasmic Treacle was 
recruited to sites of DNA damage. Laser micro-irradiation followed by fluorescence 
microscopy revealed weak accumulation of GFP-Treacle and endogenous Treacle 
within the irradiated subnuclear volume (Fig. 7d and e).  
To more robustly demonstrate that a subset of Treacle is transiently recruited to sites 
of DNA damage we exploited a transcript variant of Treacle (so-called isoform c). 
This variant uses an alternate terminal exon and lacks ten 3’ exons. The resulting 
isoform has a significantly shorter and distinct C-terminus as compared to the 
canonical transcript variant and lacks several putative nuclear and nucleolar 
localization signals (Supplementary Fig. 6a). This Treacle variant exclusively 
localized to the nucleoplasm and was efficiently recruited to microlaser-induced DNA 
breaks, likely due to the lack of competition with the strong nucleolar binding (Fig. 
7f). We next sought to determine the requirements for the mobilization of Treacle to 
DNA lesions. We first tested if NBS1 is needed for Treacle recruitment to sites of 
DSBs. Surprisingly GFP-Treacle-c was still efficiently recruited to sites of laser-
induced DNA damage in NBS1-depleted cells (Supplementary Fig. 6b). However, 
chemical inhibition of PARP activity significantly reduced Treacle association with 
DSB sites while an ATM inhibitor did not yield such an effect (Fig. 7g). In addition, 
PARP inhibition also led to a small but reproducible decrease in the number of cells 
with NBS1-GFP positive nucleoli (Supplementary Fig. 6c), indicating that Treacle 
recruitment to sites of DNA damage might be involved in mediating efficient NBS1 
nucleolar accumulation.  
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Together, these data strongly indicate that Treacle mediates DNA damage-induced 
recruitment of NBS1 in the nucleoli. Moreover, these data also show that the 
nucleoplasmic pool of Treacle is transiently recruited to sites of DNA damage in a 
manner that is partly dependent on PARP activity but is independent of ATM activity.  
 
Treacle-dependent NBS1 recruitment into the nucleoli mediates rRNA silencing 
in response to DNA damage. 
Having established that in response to DNA damage, Treacle mediates NBS1 
recruitment into the nucleoli, we next sought to determine if Treacle is involved in the 
trans-signaling process that leads to downregulation of rRNA transcription (see 
above). Treacle itself is an essential factor for efficient rRNA transcription and its 
inactivation by mutation or its downregulation by RNA interference leads to reduced 
rates of rRNA synthesis 21,22. Therefore, we carefully compared the reduction in 
rRNA transcription in response to DNA damage to the reduction in rRNA synthesis 
upon Treacle depletion. This analysis revealed that rRNA synthesis drops by about 
40% in response to DNA damage and upon depletion of Treacle, respectively. 
However, there was no further reduction of rRNA transcription in response to DNA 
damage in the absence of Treacle (Fig. 8a). This lack of an additive effect was not 
due to an exhaustion of rRNA silencing, since rRNA transcription can be reduced 
further by treatment with Actinomycin D (Fig. 8b). Therefore, these data indicate that 
the inhibition of rRNA transcription that occurs after Treacle depletion and exposure 
to DNA damage is conveyed through the same pathway. 
However, these data do not provide direct evidence that NBS1 accumulation in the 
nucleoli is negatively regulating rRNA synthesis in response to DNA damage. Thus, 
in order to strengthen this conclusion, we fused a nucleolar localization signal 
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(NOLS) to our NBS1-GFP construct and expressed it in Hela cells. Under these 
conditions recombinant NBS1-GFP-NOLS accumulated in the nucleoli in a subset of 
cells where it formed a similar focal pattern as observed after DNA damage. 
Significantly, EU labeling in those cells revealed that accumulation of NBS1 in the 
nucleoli correlates with low levels of rRNA transcription even in the absence of DNA 
damage (Fig. 8c). These data support the conclusion that Treacle-mediated NBS1 
accumulation in the nucleoli regulates rRNA silencing in response to DNA damage. 
 
 
DISCUSSION 
In this study we identified a signaling pathway that globally inhibits rRNA 
transcription in response to DSBs via an in-trans mechanism and we present 
compelling evidence that this Pol I silencing program is associated with rapid and 
transient recruitment of NBS1 into the nucleoli; a process that depends on the direct 
interaction between the NBS1 N-terminal FHA-BRCT region and the nucleolar 
phosphoprotein Treacle. This signaling mode is distinct from the previously reported 
DSB-induced transcriptional silencing that occurred in the vicinity of the DNA 
lesions and did not require long-distance signal transduction mechanisms 12,13,23. 
Specifically, we show that DNA damage induction in randomly chosen nuclear 
compartments is accompanied by a global rRNA silencing response, which demands 
trans-compartmental communication between sites of DSBs and the transcription 
machinery within the nucleoli. Mechanistically, we provide evidence that this trans-
compartmental communication is regulated by a genome surveillance complex, 
consisting of the DDR adaptor protein NBS1 and a nucleolar regulator Treacle (Fig. 
8d).  
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Our findings indicate that the communication between the repair reactions locally at 
damaged chromosomes and other vital chromatin transaction elsewhere in the nucleus 
are more widespread than previously thought, and the example of the NBS1-Treacle 
dynamics might pave the way to dissect the physiological relevance of such intra-
nuclear communication. Our previous work and this study show that nuclear 
dynamics of NBS1 is coordinated by two distinct ‘adaptor’ proteins, MDC1 and 
Treacle, respectively.  Intriguingly, NBS1 interacts with these adaptors by the same 
mechanism based on direct interaction of its N-terminal FHA-BRCT region with 
repeated acidic CK2 phosphorylation sites present both in MDC1 and Treacle. 
Moreover, the thermodynamic parameters of the association between the NBS1 N-
terminal FHA-BRCT region with phosphopeptides derived from the respective 
interaction sites in MDC1 and Treacle are virtually identical. Thus, it is likely that any 
given interaction of NBS1 molecules with either MDC1 or Treacle is mutually 
exclusive and that the relative proportion of MDC1-NBS1 versus Treacle-NBS1 
complexes only depends on the relative concentration of MDC1 and Treacle in the 
nucleoplasm. Since the steady state levels of Treacle in the nucleoplasm are very low, 
we can assume that the bulk of NBS1 associates with MDC1. Nevertheless, as we 
report in this study, a small fraction of a constitutive NBS1-Treacle complex exists, 
and can be mobilized after DNA damage.  
Mechanistically, the local increase in NBS1 concentration in the nucleoli upon 
induction of DNA damage is not yet clear. It is possible that posttranslational 
modifications of Treacle in response to DNA damage may lead to a conformational 
change that may favor Treacle-NBS1 association or facilitate release of the NBS1-
Treacle complex from DSBs. Consistent with this idea, Treacle has been identified as 
an ATM target 24 and we could confirm these results (see Supplementary Fig. 7).  
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How does Treacle-dependent NBS1 mobilization in the nucleoli mediate rRNA 
silencing in response to DNA damage? One simple mechanism may be that NBS1 
mediates its effect on rRNA transcription indirectly through Treacle. When in a 
complex with NBS1, Treacle may simply not be able anymore to promote efficient 
rRNA transcription.  
Both TCS and NBS are associated with craniofacial dysmorphism but only NBS is 
associated with microcephaly and mental retardation 4. This raises the question if the 
defect in craniofacial development in TCS and NBS are the consequence of a 
common functional role of the two affected genes, TCOF1 and NBS1, respectively. 
However, while the dysmorphic head features of NBS patients derive from a primary 
developmental defect in the formation of the brain, the cranio-facial abnormalities in 
TCS patients are likely the result of increased apoptosis in the neuronal crest stem cell 
population early during development 25. In addition, the recent finding that TCS is 
also caused by mutations in Pol I and Pol III subunits strongly supports the hypothesis 
that it is primarily a ribosomopathy 26.  
What are the benefits that cells could derive from a global rRNA silencing program 
triggered by the presence of DSBs? One intriguing possibility is provided by recent 
observations in yeast, where high rRNA transcription rates are associated with DNA 
repair defects and genome instability 27. These observations suggest that in response 
to DNA damage, transient silencing of transcriptional activity within the rDNA 
repeats may be important to maintain genome integrity. 
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FIGURE LEGENDS 
Figure 1: In-trans inhibition of Pol I transcription in response to DNA damage is 
associated with NBS1 recruitment into the nucleoli.  
(a) Measurement of rRNA synthesis after laser micro-irradiation by 5-EU 
incorporation. Location of the nucleoli is highlighted (2 independent experiments, n > 
30 cells irradiated) (b) NBS1 mobilization into the nucleoli after laser micro-
irradiation. Quantification of the percentage of cells with NBS1-GFP positive nucleoli 
is displayed in the right hand panel. Error bars represent standard error of the mean 
(S.E.M; 5 independent experiments, n > 60 cells irradiated per experiment). (c) 
Recruitment of endogenous NBS1 but not MRE11 in the nucleoli after DNA damage. 
U2OS cells were irradiated with 5 Gy, fixed after 10 min. and stained by IF with the 
indicated antibodies (2 independent experiments) (d) Quantification of NBS1-GFP 
translocation was measured as GFP-intensity in laser microirradiation tracks and as 
increase in standard deviation in the nucleoli. Error bars represent S.E.M (n = 8 
nucleoli from 5 cells; 5 independent experiments). (e) Kinetics of rRNA inhibition 
after IR measured by 5-EU incorporation. Cells were incubated with 5-EU at 
indicated timepoints after 5 Gy of IR (n > 8000 nucleoli; 1 representative of 2 
independent experiments). Scale bars in all panels: 10 µm. 	  
Figure 2: NBS1 is enriched at sites of rRNA transcription in response to DNA 
damage.  
(a) U2OS cells stably transfected with NBS1-GFP were exposed to laser micro-
irradiation. Cells were immunostained with antibodies against Pol I. Quantification of 
signal intensities was done in ImageJ by applying a single ROI to multiple color 
channels in the same image and extracting the plot profile (2 independent experiments, 
one representative image shown) Scale bars: 10 µm. (b) Schematic overview of part 
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of the rDNA repeat with the transcribed region and the first part of the intergenic 
region. Primer pairs used in the ChIP experiment in (c) and (d) are indicated at the 
promoter (H0), within the transcriped region (H1) and in the intergenic region (H18). 
(c) ChIP experiment with antibodies against mouse IgG or Pol I in U2OS cells. 
GAPDH was used as a nonspecific target. Error bars represent S.E.M (n = 3 
independent experiments). (d) ChIP experiment with antibodies against mouse IgG or 
NBS1 in stably transfected U2OS NBS1-GFP cells. GAPDH was used as a 
nonspecific target. Error bars represent S.E.M. (n = 4 independent experiments). 	  
Figure 3: The NBS1 FHA domain mediates ATM-dependent nucleolar 
accumulation of NBS1.  
(a) Quantification of the percentage of cells with NBS1-GFP positive nucleoli after 
laser micro-irradiation. Cells were treated with control or ATM siRNA for 72 h (2 
independent experiments; one representative exp. shown; n = number of cells 
analyzed; Mock: n = 184, 73; Laser: n = 115, 60). (b) Cells were transiently 
transfected with NBS1-GFP and NBS1-3A-GFP and NBS1-GFP positive nucleoli 
were quantified after laser micro-irradiation (2 independent experiments; one 
representative exp. shown; n = number of cells analyzed; Mock: n = 13, 48; Laser: n = 
7, 44). (c) As (a) but cells were transfection with siRNA against Luciferase (siLuc) or 
MDC1 (siMDC1). (2 independent experiments; one representative experiment shown; 
n = number of cells analyzed; Mock: n = 118, 103; Laser: n = 214, 121). (d) as (c) but 
cells were transiently transfected with NBS1-GFP or NBS1-R28A-GFP (2 
independent experiments; one representative experiment shown; n = number of cells 
analyzed; Mock: n = 13, 48; Laser: n = 7, 35). Scale bars in all panels: 10 µm. 
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Figure 4: TCOF1-Treacle is an interaction partner of the NBS1 FHA-BRCT 
region.  
(a) Overview of the screening procedure used to identify interaction partners of the 
NBS1 FHA-BRCT-domain. (b) A selection of interaction partners of NBS1 FHA-
BRCT identified in the screen. (c) Protein pull down from Hela nuclear extracts with 
GST-tagged BRCT (MDC1), N-terminal (1-382) NBS1 WT and an FHA-BRCT-
domain mutant (R28A, K160M=DM; (2 independent experiments; one representative 
image shown). (d) Co-immunoprecipitation of ectopically expressed Strep-tagged 
Treacle and endogenous NBS1 in 293T cells (2 independent experiments; one 
representative image shown). (e) Co-immunoprecipitation of ectopically expressed N-
terminal fragments of HA-flag-NBS1 and endogenous Treacle in 293T cells. 
Mutations were introduced to abrogate the FHA- (R28A), BRCT- (K160M) and 
FHA-BRCT-domain (DM) (2 independent experiments; one representative image 
shown). (f) Co-immunoprecipitation of endogenous Treacle and endogenous NBS1 
+/- 10 Gy of IR in 293T cells (2 independent experiments; one representative image 
shown). 	  
Figure 5: Conserved acidic SDT-like phospho-motifs in Treacle mediate the 
binding to NBS1.  
(a) Schematic overview of the protein structure of Treacle. Treacle contains a low 
complexity N-terminal region, 10 central repeats as well as a low complexity C-
terminal region. (b) Five HA-tagged deletion constructs of Treacle, lacking either the 
N-terminal region (F1), both the N-terminal and the central repeat region (F2), the 
central repeat region (F3), both the central repeat and the C-terminal region (F4) and 
the C-terminal region, respectively (F5) were used in co-immunoprecipitation 
experiments with HA affinity resin after transfection of 293T cells (2 independent 
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experiments; one representative image shown). (c) GST-pulldown with purified GST-
Treacle T-2 fragment (amino acids 109 – 330). GST-MDC1 F3 fragment 6 was used 
as a positive control.	  Note the band shift induced by CK2 phosphorylation. (d) 
Alignment of potential NBS1 binding motifs located in the N-terminus of Treacle. (e) 
ITC data for Treacle SDET, SETE, and SDSE phosphopeptides (2 independent 
experiments, one representative experiment shown).   
 
Figure 6: Phosphorylated Thr 210 in Treacle is the major interaction site for 
NBS1. 
(a) Co-immunoprecipitation of Flag-tagged N-terminal fragments of NBS1 (amino 
acids 1-382) with HA-tagged Treacle in 293T cells. Binding affinities of wt Treacle, 
T210A and STTT (S171A, T173A, T203A, T210A) were examined (2 independent 
experiments; one representative image shown). (b) Mutation of the SETE motif in 
Treacle leads to reduced NBS1 binding. Co-immunoprecipitation of N-term 
fragments of NBS1 (amino acids 1-382) with HA-tagged Treacle in 293T cells. 
Binding affinity of wt Treacle and S171A, T173A Treacle was examined. R28A, 
K160M (DM) NBS1 was used as a positive control (2 independent experiments; one 
representative image shown). (c) Schematic representation of the mass spectrometry 
approach used to identify phosphorylated Thr 210 in vivo (d) Tandem mass spectrum 
(MS-MS) of the Thr210 phosphorylated peptide sequence DEpTDVEGKPSVK from 
Treacle. The y and b series indicate fragments at amide bonds of the peptide, 
unambiguously identifying the phosphorylated Thr210. (e) Isotope cluster of the 
modified peptide sequence DEpTDVEGKPSVK from Treacle. Using high-resolution 
mass spectrometry ensures that the phosphorylated peptide is identified with parts per 
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million (ppm) accuracy (TPM = theoretical peptide mass; MPM = measured peptide 
mass; MD = mass deviation).  	  
Figure 7: Treacle mediates NBS1 nucleolar translocation in response to DNA 
damage and a fraction is transiently recruited to sites of DNA damage. 
 (a) U2OS cells were immunostained with antibodies against Treacle and Fibrillarin. 
Quantification of signal intensities using ImageJ plot profile (2 independent 
experiments; one representative image shown). (b) U2OS cells stably transfected with 
NBS1-GFP were exposed to laser micro-irradiation. Cells were immunostained with 
antibodies against Treacle. Quantification of signal intensities using ImageJ plot 
profile (2 independent experiments; one representative image shown). (c) U2OS cells 
stably transfected with NBS1-GFP were treated with Treacle siRNAs for 72 h and 
exposed to laser micro-irradiation. Cells were immunostained with antibodies against 
γH2AX. A quantification of the percentage of cells with NBS1-GFP positive nucleoli 
is displayed in the right hand panel (2 independent experiments; one representative 
image shown, >90 cells irradiated per condition). (d) U2OS cells stably transfected 
with GFP-Treacle were exposed to laser micro-irradiation (2 independent 
experiments; one representative image shown). (e) Hela cells were exposed to laser 
micro-irradiation and cells were immunostained with antibodies against Treacle and 
γH2AX (2 independent experiments; one representative image shown). (f) U2OS cells 
stably transfected with GFP-Treacle-c were exposed to laser micro-irradiation (2 
independent experiments; one representative image shown). (g) U2OS cells stably 
expressing GFP-Treacle-c were pre-treated with ATMi (KU55933) and PARPi 
(ABT888), respectively and exposed to laser micro-irradiation. Cells with increased 
GFP-Treacle-c signal within the irradiated compartment were quantified (2 
independent experiments; both results displayed in graph; n = number of cells 
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analyzed: Mock: n = 39, 31; ATMi: n = 45, 36; PARPi: n = 45, 40). Scale bars in all 
panels: 10 µm.	  
 
Figure 8: Treacle-dependent NBS1 recruitment into the nucleoli mediates rRNA 
silencing in response to DNA damage. 
(a) rRNA transcription was measured by EU labeling after transfection of cells with 
Treacle shRNA and in the presence of 2 Gy of IR. Error bars represent S.E.M. (3 
independent experiments; n represents number of cells analyzed: Con: n = 110, 100, 
90; shTreacle: n = 127, 197, 91; 2 Gy: n = 55, 89, 73; 2 Gy + shTreacle: n = 256, 48, 
71). (b) rRNA transcription was measured by EU labeling in the presence of 
Actinomycin D. Error bars represent S.E.M. (4 independent experiments; n represents 
number of cells analyzed: Mock: n = 4252, 3848, 3310, 4865; ActD: n = 4113, 3936, 
4314, 3975). (c) rRNA transcription was measured by EU labeling after transfection 
of cells with NBS1-GFP-NOLS. Quantification of signal intensities using ImageJ plot 
profile (2 independent experiments; one representative image shown). Scale bar: 10 
µm. (d) Model of Treacle-NBS1-mediated trans-compartmental communication 
between sites of DNA breaks and the nucleoli. 
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METHODS 
 
Cell culture 
U2OS, HeLa and 293T cells were grown in DME containing 10 % fetal bovine serum 
(Invitrogen), 100 U penicillin, and 100 µg/ml streptomycin. Where indicated, the 
culture medium was supplied with 50 ng/ml Actinomycin D, 10 µM ATM inhibitor 
(KU55933) or Veliparib (ABT888) for 1h. U2OS derivative cell lines expressing 
GFP-Treacle protein in a doxycycline-responsive manner were isolated by co-
transfecting U2OS cells with pcDNA6/TR (Invitrogen) and pcDNA4-TO-GFP-
Treacle constructs and selecting stably transfected cells with 400 µg/ml Zeocin and 5 
µg/ml Blasticidin S (Invitrogen). U2OS GFP-MRE11 and U2OS GFP-Treacle-c 
stably expressing cells were selected with 400 µg/ml G418. The U2OS-NBS1-GFP2 
cell line was previously described 16. 
 
Plasmids and transfections 
Transient transfections of Hela and U2OS cells were done using Lipofectamine LTX 
with plus reagent (Invitrogen) according to manufacturer’s specifications. Transient 
transfection of 293T cells was done using calcium phosphate. Full length Treacle was 
synthesized in pcDNA4-TO-strep-HA (Genscript USA inc.) and GFP was inserted to 
generate pcDNA4-TO-strep-HA-GFP-Treacle. NBS1-GFP2, NBS1-R28A-2GFP and 
NBS1-3A-2GFP (S278, S343 and S397) were described 16,28. NBS1-GFP-NOLS and 
GFP-NOLS were generated by digestion of NBS1-2GFP with BsrGI, NotI to remove 
one GFP and insert the NOLS (QDLWQWRKSL) sequence c-terminally. 
 LpEXPR-IBA103-Nterm-NBS1-NLS-FLAG-HA-Strep-WT, R28A, K160M or DM 
(R28A and K160M) was generated by insertion of N-term-NBS1 (1-380)-NLS into 
pEXPR-IBA103-oligo. GFP-Treacle-C construct was generated by insertion of the 
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TCOF1 isoform C into pAcGFP-C1. Treacle GST-fragments were generated by PCR 
amplification and subcloning into pGEX-4T3. Strep-HA-GFP-Treacle fragments were 
generated by PCR amplification and religation. Strep-HA-tagged NBS1 for co-
purification and mass spectrometry was generated by insertion of an N-terminal 
NBS1 WT/R28A fragment (1-380) into pTGSH with a C-terminal strep-HA fusion.   
 
RNA interference and site directed mutagenesis 
The siRNA oligonucleotides were obtained from Microsynth AG. For annotations and 
sequences see Supplementary Table 1. siRNA oligonucleotides targeting MRE11 
were from Ambion (MRE11 siRNA-59: AMBION 4427038, siRNA ID#:8959; 
MRE11 siRNA-60, AMBION 4427038, siRNA ID#:8960). The siRNA transfections 
were performed with 50 or 100 nM siRNA duplexes using Lipofectamine RNAiMAX 
(Invitrogen). Samples were harvested 72 h after initiation of transfection unless stated 
otherwise. For mutagenesis primer sequences see Supplementary Table 1. shRNA 
was generated by insertion of an oligo (see Supplementary Table 1) into the 
pSUPERIOR.puro vector (Oligoengine). Cells were transfected with Lipofectamine 
LTX with plus reagent (Invitrogen) according to manufacturer’s specifications and 
harvested 4-5 days post transfection. 
 
Generation of DNA damage 
X-ray irradiation was done with a XYLON.SMART 160E-1.5 device (150kV, 6 mA; 
YXLON International A/S, Taastrup, Denmark) delivering 11.8 mGy per second. Soft 
X-rays were largely filtered out with a 3 mm aluminum filter.  
 
5-EU incorporation 
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In situ detection of nascent rRNA was done with the Click-iT RNA Alexa Fluor 594, 
488 Imaging Kit (Invitrogen, Molecular Probes). Briefly, cells were incubated for 20 
min in the presence of 5-EU starting at the time of irradiation. Samples were fixed in 
4% paraformaldehyde at room temperature for 12 min and permeabilized in 0.25% 
Triton-X100 for 5 min at room temperature. Samples were then processed according 
to manufacturer’s recommendation. For high content ScanR analysis a fibrillarin 
staining was used to create a nucleolar mask for quantification of rRNA transcription. 
In general, the mean intensity of the 5-EU signal was measured within the nucleolar 
mask. In the case of ActD treated cells the total intensity of the 5-EU signal was 
measured in the nucleus. 
 
Microscopy and image analysis 
Quantitative image analysis for measurement of fluorescence intensities was done as 
described previously 29. The images were obtained with a 20x 0,75 NA 
(UPLSAPO20x) dry objective, a quadruple-band filter set for Dapi, FITC, Cy3 and 
Cy5 fluorescent dyes, a MT20 Illumination system and a digital monochrome 
Hamamatsu C9100 EM-CCD camera. Camera resolution is 200nM x 200nM per pixel 
(binning 1, 40x). Image analysis was performed with Olympus propriety ScanR 
automated image and data analysis software using standard algorithms for detection 
of nuclei and sub-objects within nuclei. Typically, 49 images (corresponding to 2000-
4000 sub-objects) were acquired under non-saturating conditions for each data point 
allowing robust measurements of experimental parameters such as intensities.  
Laser micro irradiation experiments were performed as described previously 28 with a 
PALM micro beam equipped with a 355 nm UV-A laser (Zeiss). Confocal images 
were obtained on a LSM780 (Zeiss) using a Pln Apo 40x 1.4 Oil DICII objective. All 
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images were taken under non-saturated conditions and images to be compared were 
acquired with the same settings. Non-confocal images were acquired on a Leica DMI 
6000B equipped with a Leica DFC365FX camera using the HCX PL APO 63x1.4 oil. 
Scoring of cells with NBS1-GFP2 positive nucleoli and GFP-Treacle or GFP-Treacle-
c laser stripes was done manually. Cells would be scored as positive or negative based 
on visual presence of GFP signal within nucleoli/laser tracks. Intensity plots for co-
localization were generated with the Plot Profile function in ImageJ. For co-
localization one ROI was applied to individual channels of the same image and 
intensities were measured. Time-lapse microscopy to follow accumulation of Nbs1-
GFP2 within laser tracks and in the nucleoli was done using a Axiocam MRm (Zeiss) 
and Axio Vision software. Images were obtained with a LD Plan Neofluar 40x/0.6 
corrM27 dry objective. Quantitative analysis of timelapse images was done in imageJ 
where time-lapse images were converted into stacks. Stacks were aligned using the 
StackReg plugin. After alignment a single ROI was applied to the stack and the 
average intensity or standard deviation was measure for the NBS1-GFP2 within laser 
tracks or in the nucleoli respectively.  
FRAP experiments were performed on a UltraView Vox live cell imaging system 
(Perkin Elmer) mounted on a Nikon Ti-E inverted microscope and integrated with a 
Photokinesis unit for photo-bleaching experiments. Cells were grown in glass-bottom 
Labtek dishes (Nunc, 155361) and kept under physiologic conditions for the duration 
of the experiment (37°C incubator, custom-made CO2-independent medium, covered 
by a layer of mineral oil to prevent evaporation). Images were acquired using a Nikon 
60x/1.4 APO oil objective, filter sets for GFP, and a Hamamatsu C9100-50 EMCCD 
camera using propriety Volocity software (Perkin Elmer). GFP-Treacle protein was 
bleached by a 488 nm laser (100% output, 4 iterations). The bleached region was 
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designed to bleach one nucleolus. Fluorescence recovery in the bleached region was 
monitored by acquiring 10 images prior to bleaching, 10 frames/sec for the first 3 sec 
followed by 30 frames/min for 15 minutes An unbleached region was measured in 
order to allow background subtraction. The average of signal intensities prior to 
bleaching was set to 1 and the background level to 0 and intermediate values were 
transformed accordingly.  
 
Real time PCR 
RNA was isolated with RNeasy, Quiagen. cDNA synthesis was based on 1 µg RNA 
using M-MLV Reverse Transcriptase (Promega, M170A) according to 
Manufacturer’s recommendation with random hexamer primers. Real-time PCR was 
performed using 10 ng cDNA with Roche SYBR Green I Master (Cat. 04707516001). 
Samples were analyzed on the LightCycler480 and quantified with LightCycler480 
quantification software. For primer sequences see Supplementary Table 1. 
 
Chromatin immunprecipitation 
Cells were fixed with 1% formaldehyde for 10 min and the reaction was stopped by 
addition of 1.25 M glycine. Cells were washed in cold Pbs and suspended in buffer A 
(100mM TRis-HCL pH8, 10 mM DTT), followed by 15 min incubation on ice and 15 
min incubation at 37° C. Cells were pelleted and resuspended in Buffer B (10 mM 
EDTA, 10 mM EGTA, 10 mM Hepes pH8, 0.25% TritonX-100). Again, cells were 
pelleted and resuspended in Buffer C (10 mM EDTA, 0.5 mM EGTA, 10 mM Hepes 
pH8, 200mM NaCL). Finally cells were pelleted and resuspended in lysis Buffer D 
(1% SDS, 10 mM EDTA, 50 mM Tris-HCl pH 8.1). After sonication to yield DNA 
fragments of 0.5−1 kb, 100 ug chromatin was diluted tenfold with IP buffer (16.7 mM 
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Tris-HCl pH 8.1, 167 mM NaCl, 1.2 mM EDTA, 0.01% SDS, 1.1% Triton X-100). 
Proteins of interest were immunoprecipitated with Salmon sperm DNA/Protein A/G 
Agarose (Millepore, 16-157/16-201) overnight with the respective antibodies. Beads 
were washed extensively with washing buffer 1A (10 mM Tris-HCL pH8, 150 mM 
NaCl, 0.1% SDS, 1% TritonX-100), washing buffer 1B (10 mM Tris-HCL pH8, 500 
mM NaCl, 0.1% SDS, 1% TritonX-100) and washing buffer 2 (0.25 M LiCl, 0.5% 
NP-40, 0.5% Sodiumdeoxycholate, 1 mM EDTA, 10 mM Tris-HCl pH 8) before 
elution in 100 µl Elution buffer (1% SDS, 100 mM NaHCO3). Proteinase K was 
added to each sample and reversion of crosslinks was done by heating for 1 hour at 
37° C followed by over night incubation at 65 °C. QIAquick PCR purification kit 
(Qiagen) was used to purify eluted DNA. 7% of purified DNA was amplified by 40 
cycles using a LightCycler480 (Roche) with the SYBR Green detection system. A 
standard curve was included for each primer pair in order to compare the abundance 
at different regions of the rDNA repeat.  
 
Immunological techniques 
Total cell lysates were prepared in Laemmli sample buffer (50 mM Tris, pH 6.8, 100 
mM DTT, 2% SDS, 0.1% bromophenol blue, and 10% glycerol). Alternatively, cell 
extracts were prepared by the following buffer (50 mM Tris, pH 7.5, 120 mM NaCl, 
0.5% NP-40, and 1 mM EDTA). Extracts were supplemented with 2 mM MgCl2 and 
benzonase and incubated for 30 min at 4°C. Lysates were cleared by centrifugation at 
14000 g for 15 min and protein concentration was measured using Bradford protein 
assay. Immunoprecipitations were done using Anti-Flag M2 affinity gel (Sigma, 
A2220), Monoclonal anti-HA agarose (Sigma, A2095), Dynabeads M-280 
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Streptavidin (Invitrogen, 112.05D) or Treacle antibody (Sigma Life Science, 
HPA038237), in combination with Protein A agarose.  
Other antibodies used in this study were: Mouse γH2AX (Millipore, cloneJBW302, 
cat. #:05-636), Rabbit RPA194 (Santa Cruz, sc28714), Rabbit NBS1 (Novus 
Biologicals, NB100-143), Mouse NBS1 (Genetex, Clone 1D7, GTX70224), Rabbit 
HA (Abcam, ab9110), Rabbit Flag (Sigma, F7425), Mouse Fibrillarin (Abcam, 38F3, 
ab4566), Rabbit SMC1 (Abcam, ab9262), Rabbit Bid pS61 (Bethyl, A300-527A), 
Mouse Mcm7 (Santa Cruz, DCS141, sc65469), Mouse UBF (Santa Cruz f-9, sc-
13125), Mouse GFP (Roche, 11814460001), Mouse Tubulin (Sigma, DM1A, T6199), 
Mouse Mre11 (Abcam, 12D7, ab214), Sheep MDC1 3835 (gift from Steve Jackson). 
 
Kinase assays 
CK2 phosphorylation assay and pull down were done as previously described 6 
Briefly, 100 ng of recombinant CK2a (Milipore) was added to 1 µg of purified GST-
fusion protein in CK2 kinase buffer (20 mM MOPS, pH 7.2, 25 mM β-
glycerophosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 37.5 mM MgCl2, 1 
µM ATP and 10 µCi γ-[32P]ATP and incubated from 10 min at 30°C. In case of GST-
pulldown after in vitro phosphorylation, γ-[32P]ATP was excluded. Kinase reactions 
were inactivated by boiling in SDS sample buffer and were run on SDS 
polyacrylamide gels. 
 
Isothermal titration calorimetry 
The affinity and thermodynamic parameters for NBS1 interactions with synthetic 
phosphopeptides was determined as previously described 10. Briefly, isothermal 
titration calorimetry was done with a VP-ITC instrument (MicroCal). NBS1 samples 
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were dialyzed extensively into 50 mM HEPES (pH 7.5), 150 mM NaCl, 2 mM β-
mercaptoethanol. Prior to use, all peptides were desalted and buffer exchanged using 
NAP-5 purification columns (GE Healthcare) into the relevant buffer. Peptides (0.5– 
1.5 mM) were titrated into 0.05 mM NBS1. Data were analyzed with Origin 7.0 
software. The peptide sequences were as follows: SETE: TLVpSEpTEEE; SDET: 
SSSpSDEpTDVE; SDSE: SEEpSDpSEEE. 
 
Mass spectrometry 
Double affinity purification and mass spectrometry analysis for identification of 
Treacle was done by Dualsystems Biotech AG (CaptiVate Shotgun proteomics 
service). For enrichment and mass spectrometric analysis of CK2-specific 
phosphopeptides, 293T cells were transfected with GFP-TCOF1 and harvested in high 
salt RIPA buffer (50 mM Tris pH 7.5, 400 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 
0.1% Na-deoxycholate, 2 mM Na-orthovanadate, 5 mM NaF, 5 mM Glycero-2-
phosphate, protease inhibitors (Roche)). Proteins from cleared lysate were 
precipitated in acetone, dissolved in urea, reduced with dithiothreitol, alkylated with 
chloroacetamide 30, and digested using Lys-C and modified sequencing grade trypsin 
(Sigma) followed by digestion with sequencing grade Asp-N (Promega). Protease 
digestion was terminated by addition of trifluoroacetic acid and peptides were purified 
using reversed-phase Sep-Pak C18 cartridges (Waters). CK2-specific 
phosphopeptides were enriched using the PTMScan® Phospho-CK2 Substrate Motif 
(S*DXE or T*DXE) Kit (Cell Signaling). Mass spectrometric experiments were 
performed on a nanoscale UHPLC system (EASY-nLC1000 from Proxeon 
Biosystems) connected to an Orbitrap Q-Exactive equipped with a nanoelectrospray 
source (Thermo Fisher Scientific). Each peptide fraction was auto-sampled and 
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separated on a 15 cm analytical column (75 µm ID) in-house packed with 1.9 µm C18 
beads using a 2 h gradient ranging from 5% to 40% acetonitrile in 0.5% formic acid at 
a flow rate of 200 nl/min. The Q Exactive was operated in data-dependent acquisition 
mode and all samples were analyzed using previously described ‘sensitive’ 
acquisition method 31. All raw data analysis was performed with MaxQuant software 
suite 32 version 1.3.0.5 supported by the Andromeda search engine 33. 	  
 
 	  
Supplementary	  Table	  1
Primer	  and	  siRNA	  sequences
siRNA sequences (5’ à 3’)
Treacle CCACCAUGGGUUGGAACUAAAUU-dTdT
Treacle	  shRNA CCACCATGGGTTGGAACTA
ATM	  (used	  in	  combination) TATATCACCTGTTTGTTAG-­‐dTdT
ATM	  (used	  in	  combination) AGGAGGAGCTTGGGCCTTT-­‐dTdT
NBS1	  #1 GGAGGAAGAUGUCAAUGU	  UTT-­‐dTdT
NBS1	  #2 CCAACUAAAUUGCCA	  AGUATT-­‐dTdT
MDC1 GUCUCCCAGAAGACAGUGA-­‐dTdT
Control	  (Luciferase) CGUACGCGGAAUACUUCGAT-dTdT
Treacle site-directed mutagenesis primer (5’ à 3’)
S171A CAAATACT	  CGTTGGTCGCAGAAACTGAGGAGGAG
T173A CGTTGGTCTCAGAAGCTGAGGAGGAGGGC
T203A CAGCTCCAGCGAGGACGCCTCCAGCTCCAGTGATG
T210A CTCCAGCTCCAGTGATGAGGCAGACGTGGAGGGGAAACC
Primers for pre-rRNA qRT-PCR (5’ à 3’)
pre-­‐rRNA	  forward CCGCGCTCTACCTTACCTAC
pre-­‐rRNA	  reverse GAGCGACCAAAGGAACCATA
GADDH	  forward CCCATGTTCGTCATGGGTGT
GADDH	  reverse TGGTCATGAGTCCTTCCACGATA
Primer sequences for GST-Treacle fragments (5’ à 3’)
GST-­‐frag1-­‐forward CGGGGATCCATGGCCGAGGCCAGGAAGCGGCGGGAG
GST-­‐frag1-­‐reverse GCCGAATTCTTTTTCTTTCATGCTTGATGGCAAGTC
GST-­‐frag2-­‐forward CGGGGATCCAACTCCTCAGTCCTGGGGGCGGACTTG
GST-­‐frag2-­‐	  reverse GCGCCCTCGAGGGTCTGGGAGGCTACAGCCCCTGCCTT
GST-­‐frag3-­‐forward CGGGGATCCAGAGCTGCCTCAGCCCCTGCCAAGGGG
GST-­‐	  frag3-­‐	  reverse GCCGAATTCCACCTCTCCATCACTGCTGTCTGATGA
GST-­‐frag4-­‐forward CGGGGATCCCCTGCAACCCCCTCAGCCCAGGTGGGG
GST-­‐frag4-­‐	  reverse GCCGAATTCCTGTGCTGGAGATGCAGCTGCTTCCTC
GST-­‐frag5-­‐forward CGGGGATCCGTCAAGGGGTCCTTGGGGCAAGGGATC
GST-­‐frag5-­‐	  reverse GCCGAATTCTCAAGAAGACTCCTGGTCCTGGGCAGA
GST-­‐frag6-­‐forward CGGGGATCCGGGCCTTCGGCTGCCCAGGCAGGGAAG
GST-­‐frag6-­‐	  reverse GCCGAATTCCTCACTGTCATCTGAGCTCTCAGGGGC
GST-­‐frag7-­‐forward CGGGGATCCCCCCAGAGCACCTCCGTCCAGGCCAAAGG
GST-­‐frag7-­‐	  reverse GCCGAATTCGGCCTCCCCACCTTCCCCGGCCCCCAG
GST-­‐frag8-­‐forward GCCGAATTCTACAGTCTGCTCTGCTGTCTTCTTCTTTTTC
GST-­‐frag8-­‐	  reverse CGGGGATCCGTGGACACCACCAAGGAGAGCAGCAGG
Primer sequences for HA-Treacle fragments (5’ à 3’)
HA-­‐Treacle-­‐frag1	  forward CATGGTACCCTTGTACAGCTC
HA-­‐Treacle-­‐frag1	  reverse GTGGAGGGGAAACCCTCAG
HA-­‐Treacle-­‐frag2	  forward CATGGTACCCTTGTACAGCTC
HA-­‐Treacle-­‐frag2	  reverse GTGGTGACCATGCCCACTGCC
HA-­‐Treacle-­‐frag3	  forward GGGTGTCACATCCCCCAC
HA-­‐Treacle-­‐frag3	  reverse GTGGTGACCATGCCCACTGCC
HA-­‐Treacle-­‐frag4	  forward AGCCTGGGTCAGTGGGAG
HA-­‐Treacle-­‐frag4	  reverse TGATCTAGAGGGCCCGTTTAAAC
HA-­‐Treacle-­‐frag5	  forward GGGTGTCACATCCCCCAC
HA-­‐Treacle-­‐frag5	  reverse TGATCTAGAGGGCCCGTTTAAAC
Primer sequences for ChIP analysis (5’ à 3’)
H0-­‐reverse GACGACAGGTCGCCAGAGGA
H0-­‐forward GGTATATCTTTCGCTCCGAG
H1-­‐reverse ACGTGCGCTCACCGAGAGCAG
H1-­‐forward GGCGGTTTGAGTGAGACGAGA
H18-­‐reverse GGAAGTTGTCTTCACGCCTGA
H18-­‐forward GTTGACGTACAGGGTGGACTG
GAPDH-­‐forward TACTAGCGGTTTTACGGGCG
GAPDH-­‐reverse TCGAACAGGAGGAGCAGAGAGCG
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SUPPLEMENTARY FIGURE LEGENDS 
 
Supplementary Figure 1: Additional data on rRNA silencing after DNA damage 
and NBS1 and MRE11 nucleolar localization.  
(a) Measurement of rRNA synthesis after laser-irradiation by 5-EU incorporation. A 
larger field of cells is shown here as compared to Figure 1A. (b) U2OS cells stably 
transfected with NBS1-GFP were presensitized with 10uM BrdU for 24 h and 
exposed to laser micro-irradiation. To mark nucleoli, cells were immunostained with 
antibodies against Fibrillarin. (c)	  Translocation of NBS1-GFP was followed by 
timelapse microscopy. (d)	  U2OS cells stably transfected with GFP-MRE11 were 
presensitized with 10 µM BrdU for 24 h and exposed to laser micro-irradiation. Cells 
were immunostained with antibodies against γH2AX.	  Scale	  bars:	  10	  µm. 
 
Supplementary Figure 2: Measurement of rRNA synthesis after IR by EU 
labeling.  
(a) Dose titration of rRNA synthesis after IR. Error bars represent S.E.M. (n = 3 
independent experiments). (b) rRNA synthesis after IR upon depletion of MRE11 by 
two different siRNAs (measured by EU labeling 20 min after 5 Gy). The bars in the 
graph represent the average of 2 independent experiments. 
 
Supplementary Figure 3: Measurement of rRNA synthesis after IR and CPT 
treatment by qRT-PCR.  
(a) rRNA synthesis after IR and CPT treatment in the presence of ATM inhibitor 
(KU55933). Error bars represent S.E.M. (n = 4 independent experiments; samples 
were run in duplicates). (b) rRNA synthesis after IR and CPT treatment upon 
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depletion of NBS1 by two different siRNAs. Error bars represent S.E.M. (n = 4 
independent experiments for siNBS1-1; n = 3 independent experiments for siNBS1-2; 
all samples were run in duplicates). (c) rRNA synthesis after IR and CPT treatment 
upon depletion of MDC1. Error bars represent S.E.M. (n = 4 independent 
experiments; samples were run in duplicates). 
 
Supplementary Figure 4: Treacle is heavily phosphorylated by CK2 in vitro. 
Bacterially purified GST-Treacle fragments were incubated with recombinant CK2 
and γ[32P]-ATP, followed by SDS-PAGE and autoradiography. MDC1 fragments 
were used as positive and negative control, respectively 6. Note that fragment T-2 (aa 
109-330) that contains the NBS1-interacting region is efficiently phosphorylated by 
CK2 in vitro.  
 
Supplementary Figure 5: Treacle localization and mobility in the nucleoli.  
(a) Hela cells were immunostained with antibodies against Treacle and UBF. Scale 
bar: 10 µm. (b)	  ChIP experiment with antibodies against mouse IgG or GFP in stably 
transfected U2OS GFP-Treacle cells. GAPDH was used as an unspecific target. Error 
bars represent S.E.M. (n = 4 independent experiments). (c) FRAP experiment in GFP-
Treacle-expressing Hela cells. Bleach pulse was directed against one single nucleolus 
and fluorescence recovery was measured in the same nucleolus. T1/2 = 210 ± 40 sec. 
The black line represents the median of 17 FRAP experiments included in the graph. 
 
Supplementary Figure 6: Additional data about Treacle localization to sites of 
DNA damage.  
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(a) Schematic representation of Treacle-c. Note that the C-terminal region comprising 
the nucleolar localization signal is missing from this variant. (b) U2OS cells stably 
expressing GFP-Treacle-c were pre-sensitized with 10 µM BrdU for 24 h and exposed 
to laser micro-irradiation. Cells were treated with control siRNA and siRNA against 
NBS1 and immunostained with antibodies against γH2AX. Scale bar: 10 µm (c) 
U2OS cells stably transfected with NBS1-GFP were pre-treated with PARP inhibitors 
and exposed to laser micro-irradiation. NBS1-GFP positive nucleoli were quantified. 
Error bars represent S.E.M. (3 independent experiments; n = number of cells with 
laser stripes analyzed for nucleolar NBS1 foci: Exp 1: 92, 100, 136, 85; Exp 2: 73, 61, 
64, 71; Exp 3: 63, 45, 57, 60).	  
 
Supplementary Figure 7: Treacle phosphorylation in response to DNA damage. 
293T cells were treated with the indicated siRNAs for 72h and subsequently 
transiently transfected with HA-Treacle as indicated. 1h prior to irradiation indicated 
samples were treated with 10 µM ATMi (KU55933). Cells were exposed to 10 Gy of 
IR and immunoprecipitation was performed against HA (Treacle). Blots were probed 
with the indicated antibodies, including an antibody against pSQ (pS61 Bid). 
 
Supplementary Figure 8: Full scans 	  








